Registry Study on Eosinophilic Gastrointestinal Disorders in Children and Young Adults Ages 1 to 25

What this Trial Is About

This research focuses on Eosinophilic Gastrointestinal Disorders EGIDs, including Eosinophilic Esophagitis, Gastritis, Gastroenteritis, and Colitis. It aims to better understand the symptoms patients experience during treatment, their quality of life, the diseases progression under different treatments, and any links between EGIDs and connective tissue disorders. The study is observational and seeks to gather detailed information to support future targeted treatments. Participants will be part of a registry collecting data and biological samples during routine care procedures such as endoscopies or colonoscopies. These samples will be stored indefinitely in a biorepository for research to explore disease mechanisms and severity. The study includes both patients with confirmed EGIDs and those suspected of having the condition undergoing evaluation. During the study, researchers will collect clinical information, patient-reported symptoms and quality of life measures, endoscopic and histologic findings, physical exam results, and molecular data over an average of six months to one year. This comprehensive data will help characterize EGIDs and assess disease activity and treatment responses. Participation involves follow-up through standard care visits, with no additional treatments assigned by the study team.

Eosinophilic Gastrointestinal Disorders Registry